Newstral
Tufts Center for the Study of Drug Development
- EDITORIAL: Price controls are bad medicinereviewjournal.com
- Medicare Reverses Course On Decision To Universally Cover Breakthrough Medical Devices For 4 YearsForbes
- Latest FDA-Approved Preventive Treatment For Migraine, Qulipta, Enters A Highly Competitive MarketForbes
- Public Health Is An Afterthought In Biden Administration’s $65 Billion Pandemic Preparedness InitiativeForbes
- In Parts Of The U.S., Delta Covid-19 Surge Is Forcing Hospitals To Ration ICU BedsForbes
- Incorporating The Patient’s Voice In Value Assessment And Decision-Making Regarding Use Of Medical TechnologiesForbes
- Ivermectin, A 40-Year Old Anti-Parasitic Now Embedded In A Covid-19 Culture WarForbes
- Aduhelm Could Breathe New Life Into Alzheimer’s Diagnostics Such As AmyvidForbes
- Approval Of First Interchangeable Biosimilar, Semglee, Is Sign Of An Improving U.S. Biosimilars Market, Despite ChallengesForbes
- U.S. Maternal And Infant Mortality: More Signs Of Public Health NeglectForbes
- Psychedelic Drugs Are Moving From The Fringes Of Medicine To The MainstreamForbes
- Controversial FDA Approval Of Alzheimer’s Drug Aducanumab Sets Stage For Possible Medicare Coverage BattleForbes
- Newly Approved Brexafemme, A Unique Treatment For Vaginal Yeast Infections, May Face Uptake HurdlesForbes
- Newly Approved Obesity Drug Wegovy Holds Promise, But Faces Reimbursement ChallengesForbes
- Japan’s Healthcare System Under Severe Strain, As 4th Wave Of Covid-19 Poses Threat To Olympic GamesForbes
- Covid-19 Herd Immunity Looks Like A Mirage, But Is Worth PursuingForbes
- Medicare Part D Plans Increasingly Place Generic Drugs On Non-Generic Tiers: Warped Incentives Hurt Medicare PatientsForbes
- India Is Experiencing A Devastating Wave Of Covid-19: Impact To Reverberate Around The WorldForbes
- Importance Of Formulating A U.S. Policy On Covid-19 Vaccine Passports To Facilitate Future International TravelForbes
- In Some U.S. States Booking A Vaccine Appointment Is Still A Chaotic Free-For-AllForbes
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.